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Infection of xenotransplanted human cells by xenotropic retroviruses is a known phe-
nomenon in the scientific literature, with examples cited since the early 1970s. However,
arguably, until recently, the importance of this phenomenon had not been largely recog-
nized. The emergence and subsequent debunking of Xenotropic Murine leukemia virus-
Related Virus (XMRV) as a cell culture contaminant as opposed to a potential pathogen
in several human diseases, notably prostate cancer and Chronic Fatigue Syndrome, high-
lighted a potential problem of murine endogenous gammaretroviruses infecting commonly
used human cell lines. Subsequent to the discovery of XMRV, many additional cell lines that
underwent xenotransplantation in mice have been shown to harbor murine gammaretro-
viruses. Such retroviral infection poses the threat of not only confounding experiments
performed in these cell lines via virus-induced changes in cellular behavior but also the
potential infection of other cell lines cultured in the same laboratory. Thus, the possibility
of xenotropic retroviral infection of cell lines may warrant additional precautions, such as
periodic testing for retroviral sequences in cell lines cultured in the laboratory.
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THE SEARCH FOR RETROVIRUSES ASSOCIATED WITH
HUMAN DISEASE
The considerable role of retroviruses in animal disease is well-
established. Knowing this, retroviral causes for many human
diseases have been earnestly sought. Four notable retroviral
pathogens in this respect are human T-lymphotropic virus type
1 and type 2 (HTLV-1and HTLV-2), and human immunode-
ficiency virus type 1 and type 2 (HIV-1 and HIV-2). HTLV-1
has been shown to be causal in both adult T-cell leukemia and
neurological disease (Voisset et al., 2008; Mauclère et al., 2011).
HTLV-2 has been associated with TSP/Ham-like diseases, as well
as lymphocytosis (Voisset et al., 2008; Mauclère et al., 2011). HIV-1
and 2 are both associated with acquired immunodeficiency syn-
drome (AIDS). Additional retroviruses have been implicated in a
variety of human diseases, including many cancers, neurological
disorders, and inflammatory diseases. However, establishing cau-
sation has proved exceedingly difficult for a number of reasons,
including the inability to replicate results (Voisset et al., 2008).
Despite these difficulties, the search for human disease-causing
retroviruses has remained a hot field, and much excitement can be
generated over new discoveries. Such was the case in the discovery
of Xenotropic Murine leukemia virus-Related Virus (XMRV), in
which a study describing a possible connection between this retro-
virus and prostate cancer (PCa) resulted in a hail-storm of studies
looking to connect XMRV to a number of additional human
diseases, most notably to chronic fatigue syndrome (CFS).
THE STORY OF XMRV
Xenotropic Murine leukemia virus-Related Virus was first
described in 2006, when viral sequences were detected in RNA
samples isolated from PCa tissues (Urisman et al., 2006) (the Uris-
man et al., reference appeared in a March 2006 issue of PLoS
Pathogens, and was fully retracted by the editors in September
2012). Several follow-up studies, however, did not detect XMRV
in PCa patient samples (Fischer et al., 2008; Sfanos et al., 2008;
Hohn et al., 2009; Aloia et al., 2010; Sakuma et al., 2011; Switzer
et al., 2011). In addition, studies conducted in 2009 (Schlaberg
et al., 2009) and 2010 (Arnold et al., 2010; Danielson et al., 2010)
supporting the presence of XMRV in PCa had apparent contra-
dictions to the original report as well as to each other, including
discrepancies in the presence of virus in tumor versus benign tis-
sues and discordance in cellular localization (reviewed in Sfanos
et al., 2012). Despite this, the possibility of a viral cause to PCa
proved to be an exciting prospect, prompting follow-up studies
in PCa as well as other diseases. Studies exploring the possi-
bility of XMRV involvement in different cancers, autoimmune
diseases, HIV, and even autism were reported, with differing results
(McCormick et al., 2008; Barnes et al., 2010; Cornelissen et al.,
2010; Jeziorski et al., 2010; Satterfield et al., 2010; Balada et al.,
2011; Gray et al., 2011; Lintas et al., 2011; Schmitt et al., 2011;
Tang et al., 2011; Waugh et al., 2011; Maggi et al., 2012). Of
particular concern was the detection of XMRV in sera collected
from patients with CFS (a disorder of unknown etiology char-
acterized by persistent fatigue) as well as several healthy controls
(Lombardi et al., 2009) (the Lombardi et al. reference appeared in
an October 2009 issue of Science, and was fully retracted by the
editors in December 2011). With this study came serious impli-
cations for the safety of the nation’s blood supply, prompting
immediate follow-up studies that, again, contradicted the original
report (Erlwein et al., 2010; Groom et al., 2010). An additional
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study, initially touted as the CFS “confirmatory” study, reported
the detection of murine leukemia virus (MLV) sequences in CFS
patient samples. These sequences were not XMRV however, but
polytropic endogenous MLV sequences that are present in the
mouse genome – a finding that largely implicated murine DNA
contamination of the samples (Lo et al., 2010) (the Lo et al. ref-
erence appeared in a September 2010 issue of The Proceedings of
the National Academy of Sciences, and was retracted by the authors
in January 2012). With so many contradictions building in the
literature, the role of XMRV in human disease was brought into
serious doubt.
The debunking of XMRV as a cause of human disease was
largely threefold. Firstly, mouse genomic DNA was found to con-
tain endogenous retrovirus sequences that amplified with“XMRV-
specific” primers in PCR assays (Hue et al., 2010). In 2010, a highly
sensitive PCR technique was developed to detect contaminating
murine mitochondrial cytochrome oxidase and intracisternal A
particle (IAP) sequences in DNA samples (Oakes et al., 2010).
Looking at a series of clinical samples, every sample that had been
identified as XMRV positive was also positive for murine DNA
contamination (Oakes et al., 2010; Robinson et al., 2010). In addi-
tion, many commercial reagents used to study XMRV were found
to be similarly contaminated with murine DNA, accounting for
other false-positive results in XMRV studies (Sato et al., 2010;
Erlwein et al., 2011; Tuke et al., 2011).
Next, the results of a joint study termed the Blood XMRV Scien-
tific Research Working Group (SRWG) were published (Simmons
et al., 2011). In this study, blinded samples of XMRV-spiked pos-
itive controls, clinical samples previously reported to be infected,
and negative controls were sent to nine different labs for XMRV
detection by various methods. Two of these labs, which had also
been involved in the original XMRV-CFS study, detected XRMV
in both the clinical samples and the negative controls. Another
lab that had previously reported XMRV in clinical samples, only
reported presence of the virus in the positive control samples.
These results strongly suggested issues with assay reproducibility
and false positives due to contamination (Simmons et al., 2011).
The final major blow to XMRV as a root of human disease lies in
a study in which the recombinant origin of XMRV was described
(Paprotka et al., 2011). In this study, Paprotka et al. demonstrated
that XMRV originated by recombination between two distinct
endogenous MLVs found in nude mouse strains, PreXMRV-1 and
PreXMRV-2, that were likely recombined during the xenotrans-
plantation of the PCa cell line CWR22Rv1 through nude mice.
CWR22Rv1 subsequently produced XMRV and is thought to be
the singular source of the laboratory contaminant. Supporting this
conclusion, essentially all XMRV sequences isolated from clinical
samples are the same composite sequence, with its unique sig-
nature of switch positions between PreXMRV-1 and PreXMRV-2
(Paprotka et al., 2011). Lastly, in 2012, the results of a National
Institute of Allergy and Infectious Diseases (NIAID)-sponsored
multicenter, blinded study were published, affirming that XMRV
is not present in CFS patient samples (Alter et al., 2012).
MURINE ENDOGENOUS RETROVIRUSES IN HUMAN CANCER
CELL LINES
The lesson of XMRV is a potentially important one. The fact
that XMRV arose from xenotransplantation (i.e., xenografting)
of CWR22Rv1 through mice – a very common practice when
developing cancer cell lines – is particularly concerning. Although
most researchers appear to be unaware of the potential contamina-
tion threat (Zhang et al., 2011), the infection of xenografted human
cell lines with xenotropic retroviruses is well-established in the lit-
erature, dating back to the early 1970s (Takeuchi et al., 2008; Sfanos
et al., 2011). In 1972, an endogenous feline retrovirus, RD114, was
found to have infected human rhabdomyosarcoma cells that had
been xenotransplanted through a fetal kitten brain (McAllister
et al., 1972). In 1973, there was a similar finding in that a murine
type-C retrovirus was isolated from rhabdomyosarcoma cells that
had been xenotransplanted through NIH Swiss mice (Todaro et al.,
1973). However, the implications of these and other findings have
arguably not been fully realized. To date, and particularly after
the XMRV controversy, several additional reports highlight the
widespread issue of xenotropic MLV (XMLV) contamination of
xenotransplanted cell lines (Table 1).
Hue et al. (2010) screened 411 cell lines from the Catalog of
Somatic Mutations in Cancer (COSMIC) collection by XMRV-
and XMLV-specific PCR. Nine of these lines were found to contain
contaminating XMLVs (see Table 1) (Hue et al., 2010). Like-
wise, in 2011, Sfanos et al. (2011) published a study whereby
using immunohistochemistry (IHC) and PCR techniques, they
tested 72 cell lines, including 58 of the 60 human cancer cell lines
commonly used in anti-cancer drug screens and maintained at
the NCI-Frederick (NCI-60) for the presence of XMRV or other
XMLVs. Three cell lines, in addition to CWR22Rv1, were identified
as being infected with XMLV species. Two of these were other PCa
cell lines, namely LAPC4 and VCaP, while the third was EKVX, a
non-small-cell lung carcinoma (NSCLC) cell line. Out of the four
infected lines, only CWR22Rv1 was infected with XMRV. LAPC4
and VCAP were found to harbor a virus 99% similar to a previ-
ously described XMLV,Bxv-1 (also known as XMV43). EKVX was
found to be infected with an XMLV that is 98% similar to a retro-
virus previously isolated from the B lymphoblastic cell line,DG-75.
Finally, Sfanos et al. (2011) showed, using a novel viral infectivity
assay (Aloia et al., 2013), that the XMLVs infecting LAPC4 and
VCaP were replication competent, while the virus infecting EKVX
had very low infectivity.
Concurrent with the Sfanos et al. study was a report by Zhang
et al. (2011) that sought to determine the frequency of XMLV
infection of xenografted cancer cell lines and the frequency of
XMLV spread to non-xenograft-derived lines maintained in facil-
ities that also harbor xenografted lines. The presence of MLV
sequences in 26 xenografted cell lines gathered from seven inde-
pendent laboratories was assayed by validated Taqman PCR assays.
Three cell lines were omitted due to the detection of murine DNA
contamination. Of the remaining 23 cell lines, 6 lines (1065met,
NCI-N417, LX47, LX48, CAK1, LAPC4, see Table 1) were found
to contain MLV sequences. The viral genomes found in two
xenografted cell lines (NCI-N417 and LAPC4) were then charac-
terized. Interestingly, there were previous hints that the NCI-N417
small cell lung cancer (SCLC) cell line harbored an XMLV. This
line was previously reported to express a homologous transcript
to the v-fms protooncogene via Northern blot analysis (Kiefer
et al., 1987). However, the vector used as a probe to detect v-
fms by Northern blot contained a significant amount of the pol
gene of the Susan McDonough strain of feline sarcoma virus. It
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Table 1 | Reports of XMLV infection of cancer cell lines.
Cell line Origin Xenografted?± Virus (Ref.)*
CWR22Rv1 Prostate cancer Yes XMRV (Knouf et al., 2009)
LAPC4 Prostate cancer Yes Bxv -1/N417 MLV, MLV SP(B) 1-2 (Sfanos et al., 2011;Zhang et al., 2011)
VCaP Prostate cancer Yes Bxv -1 MLV (Sfanos et al., 2011)
EKVX NSCLC Yes DG-75 MLV (Hue et al., 2010;Sfanos et al., 2011)
DG-75 Burkitt’s lymphoma No DG-75 MLV (Raisch et al., 2003)
CAK1 Pancreas cancer Yes Unidentified XMLV (Zhang et al., 2011)
LX48 SCLC Yes Unidentified XMLV (Zhang et al., 2011)
LX47 SCLC Yes Unidentified XMLV (Zhang et al., 2011)
NCI-N417 SCLC Yes N417 MLV (Zhang et al., 2011)
1065met SCLC Yes Unidentified XMLV (Zhang et al., 2011)
Jurkat J6 T cell leukemia Unknown Unidentified XMLV (Takeuchi et al., 2008)
SK-MEL-25 Melanoma No Unidentified XMLV (Deichmann et al., 2005)
SK-MEL-28** Melanoma No Unidentified XMLV (Deichmann et al., 2005)
MEL-JUSO Melanoma No Unidentified XMLV (Deichmann et al., 2005)
MML-1 Melanoma No Unidentified XMLV (Deichmann et al., 2005)
A2780 Ovarian cancer No Unidentified XMLV (Hue et al., 2010)
BHY Squamous cell carcinoma No Unidentified XMLV (Hue et al., 2010)
CoCM-1 Colon cancer No Unidentified XMLV (Hue et al., 2010)
Daudi Burkitt’s lymphoma No Unidentified XMLV (Hue et al., 2010)
IMR-5 Neuroblastoma No Unidentified XMLV (Hue et al., 2010)
MUTZ-1 Myeloid leukemia No Unidentified XMLV (Hue et al., 2010)
S-117 Thyroid sarcoma Unknown Unidentified XMLV (Hue et al., 2010)
TYK-nu Ovarian cancer Yes Unidentified XMLV (Hue et al., 2010)
±For cell lines that were not xenografted in mice, it is possible that cross-contamination from infected xenografted lines occurred, or that studies involving xenotrans-
plantation were performed with these lines, resulting in XMLV infection.
*Reference given is for viral genome sequence, if available.
**The SK-MEL-28 cell line was found to be negative for XMLVs in Hue et al. (2010) and Sfanos et al. (2011).
was subsequently discovered that the viral portion of the probe
contained significant sequence homology to AKV MLV and that
the positive signal by Northern blot analysis was not due to the
presence of v-fms, but due to the presence of MLV transcripts in
the NCI-N417 cell line (Walker et al., 1989). The viral genome iso-
lated from NCI-N417 has now been fully sequenced and deposited
in the GenBank sequence database as MLV strain N417 (GenBank
Accession number HQ246218) (Zhang et al., 2011).
Zhang et al. also sequenced two PCR products covering the
MLV gag and env gene regions from the LAPC4 cell line. These
sequences were found to be 100% identical to the N417 MLV
genome sequenced from the NCI-N417 cell line (Zhang et al.,
2011). These sequences are also 100% identical to the full viral
genome sequenced from the LAPC4 cell line by Sfanos et al.
(2011) (GenBank Accession number JF908816). As previously
mentioned, Sfanos et al. reported that the virus in LAPC4 was 99%
similar to the known XMLV Bxv-1. The N417 virus is also 99%
similar to Bxv-1, and the full-length virus sequenced by Sfanos et
al. from LAPC4 only differs from the N417 virus genome by three
bases. Zhang et al. (2011) also detected the presence of an addi-
tional virus with sequence similarity to MLV SP(B) 1–2 (GenBank
Accession number AY349140) in the LAPC4 line.
Finally, the cell culture supernatant of NCI-417, LAPC4, and
1065met were evaluated for viral infectivity, with the results
showing infective capabilities in all three cell lines (Zhang et al.,
2011).
These studies bring to light a potentially serious problem lurk-
ing within in vitro research. The danger is not isolated to the wasted
resources in researching potential disease etiology of contaminat-
ing retroviruses. There is also significant evidence to suggest that
the unknown presence of XMLVs in commonly used cancer cell
lines can have a confounding role in scientific research studies
using these contaminated lines.
INFECTION BY XMLVs LEADING TO CHANGES IN CELLULAR
BEHAVIOR
There are several potential mechanisms by which XMLVs may
modify the biological properties of a cell line, including viral
integration/insertional mutagenesis and alterations to in vivo
immunogenicity. Several recent studies on XMRV have high-
lighted the potential for XMLVs to induce changes in cellular
behavior, thus posing a potentially serious problem in the form
of confounding results of studies using infected cell lines.
In their study exploring the possible pathogenic role of XMRV
in PCa, Pandhare-Dash et al. (2012) clearly demonstrated that
infection of PCa cell lines by XMRV can induce significant changes
in cellular behavior. Two human PCa cell lines (LNCaP and PC3)
were infected with an XMRV strain isolated from a chronically
infected LNCaP line, and tested for changes in proliferation,
anchorage-independent growth, invasiveness, and matrix metallo-
proteinase (MMP) production (Pandhare-Dash et al., 2012). Both
proliferation and anchorage-independent growth increased in
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LNCaP cells, but not in PC3 cells. However, invasiveness and pro-
duction of MMP-2 and MMP-9 were increased in both cell lines.
Furthermore, p27Kipl protein levels were analyzed, and infected
LNCaP cells were found to have lower protein expression than
uninfected cells. Infected LNCaP cells were also found to have a
higher percentage of cells in S phase of the cell cycle than unin-
fected cells. Upon further analysis, Pandhare-Dash et al. found that
LNCaP cells infected with XMRV upregulated miR-221 and miR-
222 (which inhibit p27Kipl expression) compared to uninfected
cells, presenting a mechanism by which infected cells could be
downregulating p27Kipl and thus promoting progression through
the G1-S transition of the cell cycle. XMRV infection of the andro-
gen receptor (AR) negative DU145 cell line did not induce changes
in cellular proliferation or p27Kipl levels, but did induce slightly
higher levels of MMP activity versus uninfected DU145 cells. Thus,
Pandhare-Dash et al. demonstrated behavioral changes in three
different PCa cell lines due to infection with XMRV.
Stieler et al. (2012) published a report aimed at determin-
ing whether the XMRV-infected CWR22Rv1 cell line is a suit-
able PCa model. CWR22Rv1 lines that expressed significantly
reduced numbers of viral transcripts were developed using anti-
viral long terminal repeat (LTR) shRNA. Xenografted tumors
established with these lines weighed less, were significantly more
necrotic, and showed a significant reduction in blood vessel for-
mation compared to unaltered CWR22Rv1 cells (Stieler et al.,
2012). In vitro, the virus-reduced cells had significantly different
cytokine expression patterns than the unaltered CWR22Rv1 cells,
with decreased expression of OPN, TIMP2, IL-13, and CXCL14,
and increased expression of HGF. Moreover, de novo infection of
primary prostate stromal fibroblasts (PrSc cells) with replication-
competent XMRV also resulted in cytokine expression changes,
with increased expression of GROa and decreased expression of
IL-13 and TIMP1. The group also tested whether XMRV-infected
cells could affect the migration of nearby cells in a paracrine
manner. Interestingly, uninfected LNCaP cells separated from
infected PrSc cells by a permissive membrane showed a statisti-
cally significant increase in migration. In addition, stimulation of
human mammary epithelial (HMEC) cells cultured in Matrigel
with supernatant from XMRV-infected PrSc cells showed a sig-
nificant increase in tube formation, suggesting that infection with
XMRV also has a direct effect on angiogenesis. In all, Stieler et al.
(2012) showed that infection with XMRV not only affected cel-
lular behavior in vivo and in vitro and in two cellular systems
(CWR22Rv1 and PrSc cells), but that those changes in cellular
behavior can also have paracrine effects on non-infected cells.
Finally, Mohan et al. (2012) recently reported global changes in
microRNA (miRNA) expression upon XMRV infection of LNCaP
and DU145 cells. Furthermore, this group reported consistent
downregulation of miR-193a-3p and changes in miRPlus-E1245
levels that were specific to XMRV infection across four differ-
ent cell types (DU145, LNCaP, peripheral blood lymphocytes, and
monocyte-derived macrophages).
XMLV CONTAMINATION OF NON-XENOTRANSPLANTED
CELL LINES
Since many of the XMLV-infected cell lines in both the Sfanos et al.
(2011) and Zhang et al. (2011) studies were found to be replica-
tion competent, the potential for cross-contamination of other cell
lines grown in the same facilities is considerable. Indeed, Sfanos
et al. (2011) reported that XMRV-negative cell lines that were
being cultured in the laboratory at the same time as CWR22Rv1
had become contaminated. Similarly, Zhang et al. (2011) detected
XMLV infection of 13 out of 78 non-xenografted cell lines from
five different laboratories that were also culturing XMLV-infected
xenografted cell lines. In contrast, all 50 cell lines gathered from
non-xenograft culturing labs were XMLV-free. The laboratories
involved in both studies were using standard BSL2 aseptic tech-
nique, highlighting the infective potential of these XMLVs. There-
fore, the dangers of XMLV contamination of human cell lines
is not limited to xenografted lines, but potentially extends to all
additional cell lines being cultured alongside infected lines. If cont-
amination occurs and is not detected, there is significant potential
for spreading of the retrovirus, even across laboratories sharing
samples.
CONCLUDING REMARKS
Excitement quickly mounted when the first paper linking XMRV
to PCa was published, gaining sufficient momentum to fuel many
studies looking to link XMRV to many different human diseases.
The implications of XMRV having since been recognized as a
cell culture contaminant go beyond elimination of its potential
role in human disease. The discovery and subsequent debunking
of XMRV as a human pathogen brought back to light the issue
of XMLV infection of xenotransplanted cell lines. This includes
potentially artifactual experimental results due to virus-induced
changes in cellular behavior, as well as the cross-contamination of
uninfected cell lines grown in the same laboratory. With these dan-
gers in mind, precautions, such as routine testing for XMLVs in
human cell lines developed by xenotransplantation, or any cell
lines cultured in laboratories concurrently growing xenotrans-
planted or known XMLV-infected cell lines, may warrant serious
consideration.
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